Cargando…
Enrichment of stem cell-derived pancreatic beta-like cells and controlled graft size through pharmacological removal of proliferating cells
Transplantation of limited human cadaveric islets into type 1 diabetic patients results in ∼35 months of insulin independence. Direct differentiation of stem cell-derived insulin-producing beta-like cells (sBCs) that can reverse diabetes in animal models effectively removes this shortage constraint,...
Autores principales: | Shilleh, Ali H., Beard, Scott, Russ, Holger A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277834/ https://www.ncbi.nlm.nih.gov/pubmed/37315522 http://dx.doi.org/10.1016/j.stemcr.2023.05.010 |
Ejemplares similares
-
Cell Replacement Therapy for Type 1 Diabetes Patients: Potential Mechanisms Leading to Stem-Cell-Derived Pancreatic β-Cell Loss upon Transplant
por: Shilleh, Ali H., et al.
Publicado: (2023) -
Protecting Stem Cell Derived Pancreatic Beta-Like Cells From Diabetogenic T Cell Recognition
por: Castro-Gutierrez, Roberto, et al.
Publicado: (2021) -
Human pancreatic beta-like cells converted from fibroblasts
por: Zhu, Saiyong, et al.
Publicado: (2016) -
Stem-Cell-Derived β-Like Cells with a Functional PTPN2 Knockout Display Increased Immunogenicity
por: Triolo, Taylor M., et al.
Publicado: (2022) -
Epithelial-Mesenchymal Transition in Cells Expanded In Vitro from Lineage-Traced Adult Human Pancreatic Beta Cells
por: Russ, Holger A., et al.
Publicado: (2009)